PetMed Express Faces Financial Reporting Issues

Ticker: PETS · Form: 8-K · Filed: 2025-10-07T00:00:00.000Z

Sentiment: neutral

Topics: accounting-restatement, impairment, financial-reporting

Related Tickers: PETS

TL;DR

PetMed Express might have messed up its old financials, need to check.

AI Summary

PetMed Express, Inc. filed an 8-K on October 7, 2025, reporting material impairments and a non-reliance on previously issued financial statements. The filing indicates potential issues with past financial reporting, requiring further investigation and restatement. The company is based in Delray Beach, Florida.

Why It Matters

This filing suggests that PetMed Express's past financial statements may be unreliable, potentially impacting investor confidence and requiring significant accounting adjustments.

Risk Assessment

Risk Level: high — The company is disclaiming reliance on previously issued financial statements, indicating a significant accounting or reporting issue.

Key Players & Entities

FAQ

What specific financial statements are affected by the non-reliance statement?

The filing does not specify which particular financial statements are affected, but it indicates a general non-reliance on previously issued ones.

What is the nature of the material impairments reported?

The filing does not provide details on the specific nature or extent of the material impairments.

When did the events triggering this 8-K filing occur?

The earliest event reported occurred on October 1, 2025.

What is PetMed Express's principal executive office address?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the company's fiscal year end?

The company's fiscal year ends on March 31.

From the Filing

0001040130-25-000064.txt : 20251007 0001040130-25-000064.hdr.sgml : 20251007 20251007160807 ACCESSION NUMBER: 0001040130-25-000064 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251001 ITEM INFORMATION: Material Impairments ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review ITEM INFORMATION: Other Events FILED AS OF DATE: 20251007 DATE AS OF CHANGE: 20251007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251379918 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20251001.htm 8-K pets-20251001 0001040130 FALSE 0001040130 2025-10-01 2025-10-01 0001040130 us-gaap:CommonStockMember 2025-10-01 2025-10-01 0001040130 us-gaap:PreferredStockMember 2025-10-01 2025-10-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  October 1, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 2.06. Material Impairments. On October 1, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of PetMed Express, Inc. (the “Company”), upon the recommendation of the Company’s management, concluded that a $1.2 million non-cash impairment of the Company’s PCRX trade name is required to be recorded in the quarter ended March 31, 2025. The Company acquired certain intangible assets, including the PCRX trade name, in its April 2023 acquisition of the issued and outstanding equity interests of PetCareRx. The acquired PCRX trade name, an indefinite-lived int

View on Read The Filing